Company news: Ipsen, AccentHealth TV

Share this article:

Biotech Ipsen Operations appointed a new nine-person management team that will focus on its rare disease medications Somatuline Depot (lanreotide), for the hormonal growth disorder acromegaly, and Dysport (abobotulinumtoxinA) for cervical dystonia. This is just one of a series of changes—the company recently moved the hub of its US operations from California to the East Coast and announced it was investing $45 million into its R&D facility in Milford, MA. The nine-member management team includes President and General Manager, North America, Sean McKercher. McKercher helped establish the company's foothold in the US while vice president of commercial development. He will report to COO and EVP Christophe Jean.

Waiting room broadcaster AccentHealth TV added eight new condition-specific networks to its nine existing networks, which launched in May 2011. The new networks include arthritis pain, COPD, smoking cessation, gout, low testosterone, MS, osteoporosis and overactive bladder. The company also operates networks with content on allergy, mental health, asthma, diabetes, GERD, rheumatology, heart health, men's health and senior women's health.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.